Sarepta Therapeutics, Inc. SRPT Contingent Consideration Liabilities Derecognized
Contingent Consideration Liabilities Derecognized at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept srpt:ContingentConsiderationLiabilitiesDerecognized.
The official record: Sarepta Therapeutics, Inc.’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sarepta Therapeutics, Inc.'s contingent consideration liabilities derecognized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sarepta Therapeutics, Inc.'s contingent consideration liabilities derecognized?
- Sarepta Therapeutics, Inc. (SRPT) reported contingent consideration liabilities derecognized of $11.85M in Q4 2025.
- What does contingent consideration liabilities derecognized mean?
- Reflects the reduction of liabilities previously recorded for potential future payments tied to business combinations or strategic milestones that are no longer expected to be met. Derecognition of these amounts typically results in a non-cash gain on the income statement. It provides insight into the accuracy of initial acquisition valuations and the evolution of contractual obligations.